ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39726591

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC.

Yang C and 11 others. Front Immunol, 2024. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC. Papers, record 39726591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39726591

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.83, provisional
iCite
Revised in PubMed
2026-07-27
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang CChaopin
2You JJinqi
3Wang YYizhi
4Chen SSi
5Tang YYan
6Chen HHao
7Zhong HHaoran
8Song RRuyue
9Long HHao
10Xiang TTong

1 to 10 of 12Source PubMed

See all 12 authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Humans
Female
Male
Middle Aged
Aged
Tertiary Lymphoid Structures
Neoplasm Staging
Immunotherapy
Lymphocytes, Tumor-Infiltrating
CD8-Positive T-Lymphocytes
Neoadjuvant Therapy
Immune Checkpoint Inhibitors
Programmed Cell Death 1 Receptor

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137,635,247Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma.BMC Med2023https://conductscience.org/library/papers/37635247PubMed
234,289,373Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.Cell Rep2021https://conductscience.org/library/papers/34289373PubMed
334,103,353Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.J Immunother Cancer2021https://conductscience.org/library/papers/34103353PubMed
438,307,031Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism.Cell Rep Med2024https://conductscience.org/library/papers/38307031PubMed
537,379,158Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.N Engl J Med2023https://conductscience.org/library/papers/37379158PubMed
634,990,248Tertiary lymphoid structures in cancer.Science2022https://conductscience.org/library/papers/34990248PubMed
724,484,236Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.Am J Respir Crit Care Med2014https://conductscience.org/library/papers/24484236PubMed
832,580,738Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer.Genome Biol2020https://conductscience.org/library/papers/32580738PubMed
916,952,304CCR4 as a novel molecular target for immunotherapy of cancer.Cancer Sci2006https://conductscience.org/library/papers/16952304PubMed
1034,712,513Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.Oncoimmunology2021https://conductscience.org/library/papers/34712513PubMed

1 to 10 of 58

See all 58 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,598,915TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC.Thorac Cancer2026https://conductscience.org/library/papers/42598915PubMed
42,548,856Foundation model-enhanced multimodal radiomics for predicting response to chemo-immunotherapy in advanced lung squamous cell carcinoma.Front Oncol2026https://conductscience.org/library/papers/42548856PubMed
42,040,767Immunotherapy resistance and strategies in malignant pleural mesothelioma.Cancer Drug Resist2026https://conductscience.org/library/papers/42040767PubMed
41,836,417Integrative multi-omics and machine learning reveals the spatial niche distribution and role of CYP27A1+TAMs in immunotherapy response in non-small cell lung cancer.Front Immunol2026https://conductscience.org/library/papers/41836417PubMed
41,712,875Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer.JCO Precis Oncol2026https://conductscience.org/library/papers/41712875PubMed
41,430,343Tertiary lymphoid structures are associated with lower axillary residual nodal burden in breast cancer patients after neoadjuvant chemotherapy.Eur J Med Res2025https://conductscience.org/library/papers/41430343PubMed
40,211,406Immunotherapy in chronic lymphocytic leukemia: advances and challenges.Exp Hematol Oncol2025https://conductscience.org/library/papers/40211406PubMed

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCR71,236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD69969PubTator's text mininghttps://conductscience.org/library/genes/969NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
GZMB3,002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
IL7R3,575PubTator's text mininghttps://conductscience.org/library/genes/3575NCBI Gene
ITGAX3,687PubTator's text mininghttps://conductscience.org/library/genes/3687NCBI Gene
PDCD15,133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39726591

GET https://conductscience.org/api/papers/v1/39726591/references?page=2

API referenceFor AI assistants